The First Department of General Surgery, Institute of Hepatobiliary, Pancreas and Intestinal Disease, The Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China.
J Gastrointest Oncol. 2014 Feb;5(1):36-45. doi: 10.3978/j.issn.2078-6891.2013.052.
The minilaparotomy approach is technically feasible for the resection of rectal cancer in selected patients with rapid postoperative recovery and small incision. The study aimed to compare the clinical and oncological outcomes of minilaparotomy and laparoscopic approaches in patients with rectal cancer.
The 122 included patients with rectal cancer were assigned to either minilaparotomy group (n=65) or laparoscopic group (n=57) which ran from January 2005 to January 2008. Clinical characteristics, perioperative outcomes, postoperative and long-term complications, pathological results and survival rates were compared between the groups.
The demographic data of the two groups were similar. The time to normal diet (P=0.024) and the hospital stay (P=0.043) were less in the laparoscopic group than that in the minilaparotomy group. Compared with the minilaparotomy group, the mean operation time was significantly longer [low anterior resection (LAR), P=0.030; abdominoperineal resection (APR), P=0.048] and the direct costs higher for laparoscopic group (P<0.001). The morbidity and mortality were comparable between the two groups. Local recurrence was similar (5.3% laparoscopic, 1.5% minilaparotomy, P=0.520). The 5-year overall and disease-free survival rates were also similar (overall survival is 87.1% in laparoscopic group, and 82.5%in minilaparotomy group, P=0.425; disease-free survival is 74.2% in the laparoscopic group, and 71.4% in mini- laparotomy group, P=0.633).
The minilaparotomy approach was similarly safe and oncologically equivalent to laparoscopic approach for patients with rectal cancer. At the expense of a longer operative time and higher cost, laparoscopic surgery was associated with faster postoperative recovery.
小切口开腹手术在技术上是可行的,适用于选择的快速术后恢复和小切口的直肠癌患者。本研究旨在比较小切口开腹和腹腔镜手术治疗直肠癌患者的临床和肿瘤学结果。
纳入的 122 例直肠癌患者被分为小切口开腹组(n=65)或腹腔镜组(n=57),研究时间为 2005 年 1 月至 2008 年 1 月。比较两组患者的临床特征、围手术期结局、术后和长期并发症、病理结果和生存率。
两组患者的人口统计学数据相似。腹腔镜组患者的正常饮食时间(P=0.024)和住院时间(P=0.043)均短于小切口开腹组。与小切口开腹组相比,腹腔镜组的平均手术时间明显更长[低位前切除术(LAR),P=0.030;腹会阴联合切除术(APR),P=0.048],且直接费用更高(P<0.001)。两组的发病率和死亡率相当。局部复发率相似(腹腔镜组 5.3%,小切口开腹组 1.5%,P=0.520)。5 年总生存率和无病生存率也相似(腹腔镜组为 87.1%,小切口开腹组为 82.5%,P=0.425;腹腔镜组为 74.2%,小切口开腹组为 71.4%,P=0.633)。
小切口开腹术与腹腔镜术治疗直肠癌同样安全且肿瘤学结果相当。腹腔镜手术虽然手术时间较长,费用较高,但术后恢复较快。